NEU2 Rekombinanter Antikörper
NEU2 Rekombinant Antikörper für WB, IHC, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, ELISA
Konjugation
Unkonjugiert
CloneNo.
240685B3
Kat-Nr. : 83934-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83934-1-PBS bindet in WB, IHC, ELISA NEU2 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | NEU2 fusion protein Ag17386 |
| Vollständiger Name | sialidase 2 (cytosolic sialidase) |
| Berechnetes Molekulargewicht | 380 aa, 42 kDa |
| Beobachtetes Molekulargewicht | 42 kDa |
| GenBank-Zugangsnummer | BC107053 |
| Gene symbol | NEU2 |
| Gene ID (NCBI) | 4759 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
NEU2, also named as Sialidase 2, neuraminidase 2, catalyzes the hydrolytic cleavage of the terminal sialic acid (N-acetylneuraminic acid, Neu5Ac) of a glycan moiety in the catabolism of glycolipids, glycoproteins and oligosaccharides. NEU2 is localized in the cytosol and plasma membrane and takes part in myoblast and neuronal differentiation. It is almost undetectable under normal physiological conditions, and was found to be involved into apoptotic events in pancreatic ductal adenocarcinoma, one of the most dangerous cancers due to poor diagnosis and prognosis. (PMID: 30439363)







